Carbohydrate co-ingestion with protein does not further augment post-prandial muscle protein accretion in older men by Hamer, Henrike M. et al.
Hamer et al. Nutrition & Metabolism 2013, 10:15
http://www.nutritionandmetabolism.com/content/10/1/15RESEARCH Open AccessCarbohydrate co-ingestion with protein does not
further augment post-prandial muscle protein
accretion in older men
Henrike M Hamer1, Benjamin T Wall1, Alexandra Kiskini1, Anneke de Lange1, Bart BL Groen1, Jaap A Bakker2,
Annemie P Gijsen3, Lex B Verdijk1 and Luc JC van Loon1*Abstract
Background: A blunted muscle protein synthetic response to protein ingestion may contribute to the age related
loss of muscle tissue. We hypothesized that the greater endogenous insulin release following co-ingestion of
carbohydrate facilitates post-prandial muscle protein accretion after ingesting a meal-like bolus of protein in older
males.
Methods: Twenty-four healthy older men (75±1 y) were randomly assigned to ingest 20 g intrinsically L-[1-13C]
phenylalanine-labeled casein protein with (PRO-CHO) or without (PRO) 40 g carbohydrate. Ingestion of specifically
produced intrinsically L-[1-13C] phenylalanine labeled protein allowed us to assess post-prandial incorporation of
dietary protein derived amino acids into muscle protein. Blood samples were collected at regular intervals, with
muscle biopsies being obtained prior to and 2 and 6 h after protein ingestion.
Results: Plasma glucose and insulin concentrations showed a greater increase in PRO-CHO compared with PRO
(P<0.001). Muscle protein-bound L-[1-13C] phenylalanine enrichments tended to increase to a greater extent in PRO-
CHO compared with PRO during the first 2 h after protein ingestion (0.0072±0.0013 vs 0.0046±0.010 MPE,
respectively; P=0.13). However, 6 h after protein ingestion, differences in muscle protein-bound L-[1-13C]
phenylalanine enrichments were no longer observed between experiments (0.0213±0.0024 vs 0.0185±0.0010 MPE,
respectively; P=0.30).
Conclusions: This study shows that carbohydrate ingestion may accelerate, but does not further augment post-
prandial incorporation of dietary protein derived amino acids into muscle protein in healthy elderly men.
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Ageing is associated with the loss of muscle mass and
strength, which reduces functional capacity and increases
the risk of developing chronic metabolic diseases [1]. Re-
cent work suggests that with ageing skeletal muscle tissue
becomes less sensitive to the main anabolic stimuli, i.e.
food intake and physical activity [2-5]. The proposed
blunted muscle protein synthetic response to protein in-
gestion, coined “anabolic resistance”, has been suggested
to represent a key factor responsible for the progressive* Correspondence: l.vanloon@maastrichtuniversity.nl
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reproduction in any medium, provided the orloss of skeletal muscle mass with ageing [2-6]. Conse-
quently, many research groups have started to look for
dietary strategies that stimulate post-prandial muscle pro-
tein synthesis [7-9]. Dietary protein has been identified as
the main factor driving the muscle protein synthetic re-
sponse to food intake [10]. However, other macronutrients
may modulate the post-prandial muscle protein synthetic
response to protein ingestion.
Previous work suggests that carbohydrate co-ingestion
with protein stimulates post-prandial muscle protein
accretion [10-14]. The latter could be attributed to the
higher energy intake and/or the greater post-prandial
insulin release following carbohydrate co-ingestion. In
agreement, higher insulin concentrations have beenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Subjects’ characteristics
PRO PRO-CHO
n 12 12
Age (y) 74.3 ± 1.2 74.8 ± 1.0
Weight (kg) 78.4 ± 1.9 78.4 ± 2.1
BMI (kg/m2) 25.7 ± 0.4 25.8 ± 0.7
Systolic blood pressure (mmHg) 140 ± 5 145 ± 5
Diastolic blood pressure (mmHg) 74 ± 3 71 ± 4
Fat (%) 22.3 ± 1.3 23.2 ± 1.1
Lean body mass (kg) 58.5 ± 1.1 57.5 ± 1.1
Basal plasma glucose (mmol.L-1) 5.4 ± 0.1 5.4 ± 0.1
Plasma glucose OGTT t=120 min (mmol.L-1) 6.3 ± 0.5 6.0 ± 0.6
Basal plasma insulin (mU.L-1) 21 ± 2 21 ± 2
Plasma insulin OGTT t=120 min (mU.L-1) 93 ± 19 94 ± 16
HbA1c (%) 5.7 ± 0.1 5.7 ± 0.1
HOMA 5.1 ± 0.5 5.1 ± 0.6
OGIS (mL.min.m-1) 347 ± 17 346 ± 16
Values represent means±SEM. HbA1c: glycated hemoglobin; OGTT:
oral-glucose-tolerance-test; HOMA: Homeostasis Model Assessment; OGIS:
Oral Glucose Insulin Sensitivity. Data were analysed with a two-tailed
unpaired t-test. No significant differences between groups.
Hamer et al. Nutrition & Metabolism 2013, 10:15 Page 2 of 9
http://www.nutritionandmetabolism.com/content/10/1/15reported to stimulate muscle protein synthesis rates under
conditions of hyperaminoacidemia [15]. However, there is
an on-going debate on whether circulating insulin levels
regulate muscle protein synthesis [16,17]. Based on a
series of clamp studies that assessed muscle protein syn-
thesis rates at various levels of circulating insulin [18,19],
it has been proposed that insulin is merely permissive, ra-
ther than modulatory, to stimulate muscle protein synthe-
sis in healthy young adults [16].
In contrast, this paradigm regarding the proposed per-
missive role of post-prandial insulin concentrations may
not be applicable in older individuals. Higher insulin
concentrations may be required to allow an appropriate
post-prandial rise in muscle protein synthesis rates in the
elderly population. The stimulation of endogenous insulin
release following food intake represents a key factor dri-
ving post-prandial perfusion, allowing subsequent amino
acid delivery to the muscle, facilitating amino acid uptake
and/or activating anabolic signalling [20]. The decreased
insulin sensitivity observed with ageing is associated with
blunted endothelial-dependent vasodilation [21]. It has
therefore been proposed that senescent muscle is more
resistant to the stimulating effect of post-prandial insulin
levels on muscle perfusion and, as such, amino acid deli-
very to the muscle [22,23]. In agreement, work by Fujita
et al. [11] has shown that local insulin administration in
older adults increases muscle protein synthesis rates.
These studies suggest that increasing post-prandial insulin
release following food intake may augment amino acid
delivery to the muscle, thereby increasing post-prandial
muscle protein synthesis rates in the older population.
We hypothesize that co-ingesting carbohydrate increa-
ses the post-prandial muscle protein synthetic response
to the ingestion of a meal-like bolus of protein in healthy
older men. Therefore, we selected 24 older men (age:
75±1 y) in whom we determined the muscle protein
synthetic response to the ingestion of 20 g dietary pro-
tein with or without 40 g carbohydrate during a 6 h
post-prandial period. As presented in previous work
from our laboratory [8,24-26] we applied specifically
produced intrinsically L-[1-13C] phenylalanine labeled
casein protein with a high enrichment level (37.4 MPE)
to assess post-prandial incorporation of dietary protein
derived L-[1-13C] phenylalanine into muscle protein.
The present study is the first to provide evidence that
greater energy intake or high post-prandial insulin levels
are not required to increase the post-prandial muscle
protein synthetic response to the ingestion of a meal like
bolus of dietary protein ingestion in older individuals.
Methods
Subjects
Twenty-four healthy elderly men (age: 75±1 y, body mass
index (BMI): 25.8±0.4 kg∙m-2) were selected to participatein the present study. Only male subjects were included,
since protein synthesis rates have been shown to differ be-
tween men and women [27]. The subjects were randomly
assigned to an experiment in which a single meal like
bolus of protein with (PRO-CHO) or without (PRO) add-
itional carbohydrate was ingested. Subjects’ characteristics
are presented in Table 1. Exclusion criteria were BMI
>30 kg∙m-2, diabetes, all co-morbidities interacting
with mobility and muscle metabolism of the lower limbs
(e.g. arthrosis, arthritis, spasticity/rigidity, all neuro-
logical disorders and paralysis), use of anticoagulants,
blood diseases, phenylketonuria, allergy for lidocain and
participation in any regular exercise program. This
study was conducted according to the guidelines laid
down in the Declaration of Helsinki and all procedures
involving human subjects were approved by the Medical
Ethics Committee of the Maastricht University Medical
Centre. Written informed consent was obtained from all
subjects.
Pretesting
Prior to selection, all subjects participated in a routine
medical screening. Subjects completed a health and acti-
vity questionnaire and underwent an oral-glucose-toler-
ance test (OGTT) to screen for type 2 diabetes according
to the criteria set out by the World Health Organization
[28]. Venous plasma glucose and insulin concentrations
determined during the OGTT were used to determine the
oral glucose insulin sensitivity (OGIS) index [29] and the
homeostasis model assessment (HOMA) index [30]. Prior
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body composition was determined by dual-energy X-ray
absorptiometry (DXA, Discovery A; Hologic, Bedford, USA).
Diet and activity before testing
All subjects consumed a standardized meal (33±2 kJ.kg
body weight, providing 44% energy (En%) carbohydrate,
22 En% protein, and 34 En% fat) the evening prior to the
experiment. All volunteers refrained from strenuous
physical activity and maintained their habitual diet for at
least 2 d preceding the experiment.
Protocol
At 0800, after an overnight fast, subjects arrived at the la-
boratory by car or public transport. A polytetrafluoro-
ethylene catheter was inserted into a heated dorsal hand
vein after which the hand was placed in a hot box (60°C)
to allow arterialized venous blood sampling [31]. After a
basal arterialized blood sample was collected, a fasting
muscle biopsy sample was obtained from the vastus
lateralis muscle. Subjects then ingested a single bolus of
test drink containing 20 g intrinsically L-[1-13C] phenyl-
alanine labeled casein. In the PRO-CHO group, 40 g
carbohydrate (50% dextrose monohydrate; Avebe Food,
Veendam, the Netherlands, 50% maltodextrin; AppliChem
GmbH, Darmstand, Germany) was added to the test
drink. The consumption of the test drink with or without
carbohydrate marked the beginning (t= 0 min) of a 6 h
post-prandial assessment period. Arterialized blood
samples were subsequently collected at t = 15, 30, 45, 60,
90, 120, 150, 180, 210, 240, 270, 300, 330, and 360 min. A
second muscle biopsy sample was taken from the same
limb, through a new incision, >2 cm distal from the first
incision at t = 120 min. A third muscle biopsy sample was
collected from the contralateral leg at t= 360 min.
Arterialized venous blood samples were collected into
pre-chilled EDTA-containing tubes and centrifuged at
1000g for 10 min at 4°C. Aliquots of plasma were frozen
in liquid nitrogen and stored at −80°C until further ana-
lysis. Muscle biopsy samples were obtained from the mid-
dle region of the vastus lateralis, 15 cm above the patella
and ~3 cm below entry through the fascia using the per-
cutaneous needle biopsy technique [32]. Muscle biopsy
samples were carefully dissected and freed from any vis-
ible non-muscle material and then immediately frozen in
liquid nitrogen and stored at −80°C until further analysis.
Preparation of intrinsically labeled protein
Intrinsically L-[1-13C] phenylalanine-labeled micellar ca-
sein protein was obtained by infusing a Holstein cow with
large quantities of L-[1-13C] phenylalanine, collecting milk,
and purifying the casein fraction as described previously
[33]. The L-[1-13C] phenylalanine enrichment in the ca-
sein fraction averaged 37.4 mole percent excess (MPE).The casein protein met all chemical and bacteriological
specifications for human consumption. Subjects received a
total beverage volume of 450 mL, which provided 20 g
casein protein. Drinks were flavoured by adding 2 mL
vanilla flavour (Givaudan, Naarden, the Netherlands) per L
beverage.
Plasma analyses
Plasma glucose concentrations were analysed with an
automatic analyser ABX Pentra 400 (Horiba ABX Diag-
nostics, Nijmegen, the Netherlands) using an ABX Pentra
Glucose HK CP Kit (A11A01667, Horiba ABX Diagnos-
tics). Insulin was analysed by radioimmunoassay using a
commercially available kit (Insulin RIA kit HI-14K;
Millipore, Billerica, USA). For determination of plasma
amino acid concentrations, 10 μl of plasma was mixed
with 1500 μl of 0.5 mM Tridecafluoroheptanoic acid
(TDFHA) (Sigma, Zwijndrecht, The Netherlands) in water
and 10 μl of the internal standard solution containing
stable isotope-labeled amino acids (Cambridge Isotope
Laboratories, Inc., Andover, USA) in 0.1 M HCl [34].
Amino acid concentrations were determined using ultra-
performance liquid chromatography tandem mass spec-
trometry (UPLC-MS/MS) as described previously [34].
For plasma phenylalanine enrichment measurements,
plasma phenylalanine was derivatised to its t-butyldi-
methylsilyl (TBDMS) derivative, and the [1-13C] phenyl-
alanine enrichment was determined by electron ionization
gas chromatography–mass spectrometry (GC-MS, model
7890AN GC/5975C MSD; Agilent, Little Falls, USA) by
using selected ion monitoring of masses 336 and 337 for
unlabeled and 1-13C labeled phenylalanine, respectively
[35]. Standard regression curves were applied in all iso-
topic enrichment analyses to assess the linearity of the
mass spectrometer and to control for the loss of tracer.
Enrichments (MPE) were corrected for the natural abun-
dance of 13C phenylalanine [36].
Muscle tissue analyses
For the measurement of L-[1-13C] phenylalanine enrich-
ment in the tissue-free amino acid pool and mixed muscle
protein, 40–60 mg wet muscle was freeze dried. Collagen,
blood, and other non-muscle fibre material were removed
from the muscle fibres under a light microscope. The
isolated muscle fibre mass was weighed, and 35 volumes
(7 × dry weight of isolated muscle fibres × wet/dry weight
ratio) of ice-cold 2% perchloric acid were added. The tis-
sue was then homogenized by sonification (3 × 10 sec
with 10 sec in-between time intervals) and centrifuged (at
1160 g for 20 min at 4°C). The supernatant was collected
and processed in the same manner as the plasma samples,
such that tissue-free L-[1-13C] phenylalanine enrichment
could be measured by using its TBDMS derivative on a
GC-MS. The protein pellet was washed with 3 additional
Hamer et al. Nutrition & Metabolism 2013, 10:15 Page 4 of 9
http://www.nutritionandmetabolism.com/content/10/1/151 mL washes of 2% perchloric acid, dried, and hydrolysed
in 6 M HCl at 120°C for 15 to 18 h. The hydrolysed pro-
tein fraction was dried under a nitrogen stream while
heated to 120°C. A 50% acetic acid solution was then
added, and the hydrolysed protein was passed over a
Dowex exchange resin (AG 50W-X8, 100–200 mesh
hydrogen form; Bio-Rad, Hercules, USA) by using 1M
HCl, H2O and 2 M NH4OH as eluents. The NH4OH frac-
tion was collected and used for further analysis. L-[1-13C]
phenylalanine enrichment was determined by deriva-
tisation to its N(O,S)-ethoxycarbonyl ethyl ester. The
enrichment of the derivative was measured by GC-C
-IRMS (MAT 253; Thermo Scientific, Bremen, Germany)
by using an HP-Ultra 1 GC-column (no. 19091A-112;
Hewlett Packard, USA), GC Isolink, and monitoring of
ion masses 44, 45 and 46. By establishing the relationship
between the enrichment of a series of L-[1-13C] phenyl-
alanine standards of variable enrichment and the en-
richment of the N(O,S)-ethoxycarbonyl ethyl esters of
these standards, the muscle protein-bound enrichment of
phenylalanine was determined. Standard regression curves
were applied to assess the linearity of the mass spectrom-
eter and to control for the loss of tracer. The coefficient of
variation for the measurement of L-[1-13C] phenylalanine
enrichment in mixed muscle protein averaged 0.46±0.02%.
Calculation of mixed muscle protein fractional synthetic
rate from the ingested casein
The muscle protein fractional synthetic rate (FSR) from
the ingested casein over the 6 h post-prandial period
was calculated using the standard precursor product re-
lationship [37]. Muscle FSR was calculated as follows:
FSR ¼ ΔEp
Eprecursor  t  100
Where ΔEp is the delta increment of muscle protein
bound L-[1-13C] phenylalanine enrichment (MPE) du-
ring the incorporation period, Eprecursor is the average
values of plasma L-[1-13C] phenylalanine or muscle free
enrichments (MPE) during the incorporation period and
t is the time interval (h) between biopsy samples [38].
Statistics
All data are expressed as means±SEMs. The plasma insulin
and glucose responses were calculated as the positive incre-
mental area under the curve (iAUC) above baseline values.
Differences in baseline values (i.e. age, weight, BMI, body
composition, blood pressure, glucose tolerance) were
determined using an unpaired, two-tailed Student’s t-Test.
Two-way ANOVA with time as within subjects factor and
group (i.e. treatment) as between subjects factor was used to
compare differences between treatments over time in plasma
glucose and insulin concentrations, plasma amino acidconcentrations and plasma L-[1-13C] phenylalanine en-
richments. In case of a significant interaction between time
and treatment, Bonferroni post-tests were applied to locate
the differences. Differences between treatments in iAUC of
plasma glucose and insulin, muscle free and protein-bound
L-[1-13C] phenylalanine enrichments andmixedmuscle FSR
were analysed with an unpaired, two-tailed Student’s t-Test.
Correlations between plasma and muscle free L-[1-13C]
phenylalanine enrichments were assessed by calculation
Pearson’s correlations coefficients. Statistical significance
was set at P<0.05. All calculations were performed by using
the PASW statistics 18.0.3 software package.
Results
Plasma glucose and insulin
Plasma glucose and insulin concentrations in the PRO
and PRO-CHO experiment are shown in Figure 1. Plasma
glucose concentrations (Figure 1A) significantly increased
after ingestion of casein plus carbohydrate (PRO-CHO),
whereas no significant increase was observed after inges-
tion of casein only (Significant time (P<0.0001), treatment
(P<0.0001) and interaction (P<0.0001) effect). In accor-
dance, the plasma glucose response (iAUC) was signi-
ficantly greater in the PRO-CHO compared with the PRO
experiment (288±34 vs. 13±5 mmol.L-1.6 h-1, respectively;
P<0.0001). Plasma insulin concentrations (Figure 1B)
showed a rapid increase following drink ingestion in both
groups, although plasma insulin concentrations reached
significantly higher concentrations in the PRO-CHO
compared with the PRO experiment (Significant time
(P<0.0001), treatment (P=0.0002) and interaction (P<0.0001)
effect). In accordance, the plasma insulin response (iAUC)
was significantly greater in the PRO-CHO compared with
the PRO experiment (8421±1054 vs. 1058±234 mU.L-1.6 h-1,
respectively; P<0.0001). Plasma amino acids
Plasma phenylalanine (A), leucine (B), total essential
amino acid (EAA; C), total branched chain amino acid
(BCAA; D), total amino acid (E) and non-essential amino
acid (NEAA; F) concentrations over time are depicted in
Figure 2. Following protein ingestion, a rapid increase in
plasma amino acid concentrations was observed in both
experiments (P<0.0001). Plasma phenylalanine concen-
trations did not differ between experiments, whereas
plasma leucine concentrations were significantly lower in
the PRO-CHO compared with the PRO experiment be-
tween 30–180 min following ingestion of the drink. In line,
total plasma BCAA concentrations were significantly lower
in the PRO-CHO compared with the PRO experiment
group during the same time period. Total plasma EAA
concentrations were significantly lower in the PRO-CHO
experiment between 45–60 min following protein ingestion
(P<0.05). Total plasma NEAA concentrations did not differ
significantly between experiments. Plasma L-[1-13C]
phenylalanine enrichments
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Figure 1 plasma glucose (A) and insulin (B) concentrations.
Mean (±SEM) plasma glucose (A) and insulin (B) concentrations
following ingestion of 20 g casein with (PRO-CHO; n=12) or without
(PRO; n=12) 40 g carbohydrate in healthy older men. Glucose:
significant time (P<0.0001), treatment (P<0.0001) and interaction
(P<0.0001) effect. Insulin: significant time (P<0.0001), treatment
(P=0.0002) and interaction (P<0.0001) effect. * = significantly greater
when compared with the PRO experiment (P<0.05).
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ment over time is illustrated in Figure 3. Following inges-
tion of 20 g intrinsically L-[1-13C] phenylalanine-labeled
casein, plasma L-[1-13C] phenylalanine enrichments
increased rapidly in both experiments (significant time
(P<0.0001) and interaction (P<0.0009) effect). Peak plasma
L-[1-13C] phenylalanine enrichments did not differ be-
tween groups and averaged 11.2±0.6 and 11.2±1.2 MPE in
the PRO and PRO-CHO experiment, respectively. How-
ever, peak levels were reached much earlier in the PRO
group (at t=45 versus t=120 min, respectively). Muscle
tracer analysis
Muscle free L-[1-13C] phenylalanine enrichments (MPE)
at 2 and 6 h following into the post-prandial period are
shown in Figure 3. Muscle free L-[1-13C] phenylalanine
enrichments at 2 h following the drink averaged 5.1±0.4
and 6.1±0.7 MPE in the PRO and PRO-CHO experiment,
respectively (P=0.29). At 6 h following the drink muscle
free L-[1-13C] phenylalanine enrichments had declined to2.5±0.2 and 2.7±0.3 MPE, respectively (P=0.65). A strong
significant correlation was observed between plasma and
muscle free L-[1-13C] phenylalanine enrichment at 2 h
(r=0.89; P<0.0001) and 6 h (r=0.92; P<0.0001). Muscle
protein-bound L-[1-13C] phenylalanine enrichments
(MPE) assessed 2 and 6 h after protein ingestion are
shown in Figure 4. Muscle protein-bound L-[1-13C]
phenylalanine enrichments at 2 h tended to be higher in
the PRO-CHO compared with PRO experiment (0.0072
±0.0013 vs 0.0046±0.0010 MPE: P=0.13). At 6 h after
protein ingestion muscle protein-bound L-[1-13C] phenyl-
alanine enrichments no longer differed between expe-
riments and averaged 0.0213±0.0024 and 0.0185±0.0010
MPE in the PRO-CHO and PRO experiment, respectively
(P=0.30). Post-prandial amino acid deposition from diet-
ary protein in the muscle protein pool was 59% and 15%
greater following carbohydrate co-ingestion (PRO-CHO)
when compared to the ingestion of protein only (PRO), at
2 and 6 h after protein ingestion, respectively. Mixed
muscle protein fractional synthetic rates calculated over
the entire 6 h post-prandial period, with the plasma tracer
enrichments used as the precursor pool, did not differ be-
tween groups (0.0438±0.0046 vs 0.0400±0.0026 %.h-1, in
the PRO-CHO and the PRO group, respectively; P=0.48).
Similarly, when muscle free L-[1-13C] phenylalanine enr-
ichments were used as a precursor to calculate FSR over
the entire 6 h post-prandial period no differences were
observed between groups (0.088±0.009 vs 0.099±0.008, in
the PRO-CHO and the PRO group, respectively; P=0.44).
Discussion
In the present study, older men ingested intrinsically la-
beled dietary protein to assess the subsequent incorpor-
ation of the dietary protein derived amino acids into
mixed muscle protein. We compared the post-prandial
muscle protein synthetic response after ingesting a single
meal-like (20 g) amount of dietary protein with or without
40 g carbohydrate in healthy older men. Carbohydrate co-
ingestion strongly stimulated post-prandial insulin release.
However, carbohydrate co-ingestion did not augment the
post-prandial use of the ingested protein derived amino
acids for muscle protein synthesis during a 6 h post-
prandial period in healthy older men.
Previous work suggests that co-ingestion of other macro-
nutrients with protein may modulate the post-prandial
muscle protein synthetic response [11-15,39,40]. In the
present study, we assessed whether post-prandial muscle
protein accretion following the ingestion of a meal-like
amount of casein protein could be augmented by adding
40 g carbohydrate. Therefore, we applied specifically pro-
duced intrinsically L-[1-13C] phenylalanine labeled dietary
protein which allowed us to assess the metabolic fate of
the ingested protein towards its incorporation into muscle
protein [33,41]. Importantly, this allows us to investigate
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Figure 2 Mean (±SEM) plasma phenylalanine (A), leucine (B), total branched chain amino acids (BCAA; C), total essential amino acids
(EAA; D), total non-essential amino acids (NEAA; E) and total amino acid (AA; F) concentrations following ingestion of 20 g casein with
(PRO-CHO; n=12) or without (PRO; n=12) 40 g carbohydrate in healthy older men. Phenylalanine: significant time (P<0.0001) and
interaction (P=0.0441) effect. Leucine: significant time (P<0.0001), treatment (P<0.0001) and interaction (P<0.0001) effect. Total BCAA: significant
time (P<0.0001), treatment (P=0.0006) and interaction (P<0.0001) effect. Total EAA: significant time (P<0.0001), treatment (P=0.0182) and
interaction (P=0.0028) effect. Total NEAA: significant time (P<0.0001) and interaction (P=0.0004) effect. Total AA: significant time (P<0.0001) and
interaction (P<0.0012) effect. *= significantly lower when compared with the PRO experiment (P<0.05).
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siological (i.e. bolus feeding) setting. Carbohydrate co-
ingestion strongly elevated plasma insulin concentrations
with peak values of 138±18 vs. 34±5 mU . L-1, in the PRO-
CHO and PRO experiment, respectively. After 90 min,
plasma insulin concentrations no longer differed between
experimental conditions (Figure 1). In agreement with pre-
vious work [42,43], the greater insulin response seemed to
modulate the plasma amino acid kinetics (Figure 2).
Carbohydrate co-ingestion attenuated the post-prandial
rise in plasma amino acid concentrations, mainly the
branched chain amino acids (Figure 2). Plasma [1-13C]phenylalanine enrichments were also significantly lower in
the PRO-CHO vs. PRO experiment, during the first 90
min after protein ingestion (Figure 3). The attenuated rise
in plasma phenylalanine concentration and [1-13C] phenyl-
alanine enrichment following carbohydrate co-ingestion
coincided with the greater rise in circulating insulin levels,
implying that (muscle) tissue amino acid uptake was
accelerated during the early post-prandial phase in the
PRO-CHO experiment.
An insulin induced stimulation of amino acid uptake
could allow a more rapid provision of amino acids avail-
able for muscle protein synthesis. In accordance, we
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Figure 3 Mean (±SEM) plasma and muscle free L-[1-13C]
phenylalanine enrichments following ingestion of 20 g
intrinsically L-[1-13C] phenylalanine-labeled casein protein with
(PRO-CHO; n=12) or without (PRO; n=12) 40 g carbohydrate in
healthy older men. No significant differences in muscle free L-[1-
13C] phenylalanine enrichments were observed between
experiments. A significant time (P<0.0001) and interaction (P<0.0009)
effect was found for plasma L-[1-13C] phenylalanine enrichments. *=
significantly lower when compared with the PRO
experiment (P<0.05).
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dietary protein derived L-[1-13C] phenylalanine into skel-
etal muscle protein during the first 2 hours after protein
ingestion when carbohydrate was co-ingested (P=0.13;
Figure 4).
The suggested impact of carbohydrate ingestion on
muscle protein accretion during the early post-prandial
phase was not maintained. Incorporation of dietary pro-
tein derived L-[1-13C] phenylalanine into skeletal muscle
protein during the 6 h following protein ingestion did
not differ between experimental conditions and averaged2 h 6 h
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Figure 4 Mean (±SEM) muscle protein-bound L-[1-13C]
phenylalanine enrichments (MPE) at 2 and 6 h following the
ingestion of 20 g intrinsically L-[1-13C] phenylalanine-labeled
casein with (PRO-CHO; n=12) or without (PRO; n=12) 40 g
carbohydrate in healthy older men. No significant differences
were observed between experiments. There was a tendency for
greater muscle protein accretion in the CHO+PRO experiment
during the early post-prandial period (P=0.13).0.0213±0.0024 and 0.0185±0.0010 MPE in PRO-CHO
and PRO, respectively (P=0.30; Figure 4). From these
data we can conclude that carbohydrate co-ingestion
may accelerate, but does not modify the metabolic fate
of dietary protein derived amino acids for muscle pro-
tein synthesis over a 6 h post-prandial period in older
men.
Our results suggest that the post-prandial insulin re-
sponse following ingestion of 20 g casein only was already
sufficient to maximize insulin-mediated stimulation of
muscle protein synthesis. This finding is consistent with
Greenhaff et al. [18] who demonstrated that under clamp
conditions insulin concentrations of merely 5–15 mU.L-1
are already sufficient to allow maximal stimulation of
muscle protein synthesis rate during hyperaminoacidemic
conditions in healthy young men. However, the latter has
been questioned for the older population, as insulin resist-
ance in senescent muscle has been associated with
impaired insulin stimulated endothelial-dependent vaso-
dilation [13-15]. Therefore, it can be hypothesized that
higher post-prandial insulin concentrations are required
to maximize the muscle protein synthetic response to food
intake in the older population. Though the present data
indicate that a greater post-prandial insulin response in
the older population may accelerate the use of dietary pro-
tein derived amino acids for muscle protein synthesis, this
does not modulate the total 6 h post-prandial muscle pro-
tein synthetic response. Discrepancies between the present
results and previously published work [11-15,39] may be
attributed to differences in study design with the other
studies using a continuous supply of extra amino acids
and/or carbohydrate rather than a single bolus. Neverthe-
less, this does not mean that the post-prandial muscle
protein synthetic response cannot be further increased in
the elderly population. Recently, we showed that by
ingesting more protein (35 over 20 g), post-prandial diet-
ary protein derived amino acid incorporation rates can be
further improved [25]. Though we can only speculate on
the impact of carbohydrate co-ingestion and/or greater in-
sulin release on post-prandial muscle protein synthesis
following ingestion of greater amounts of dietary protein,
these combined findings may be used to suggest that more
protein dense meals should be consumed by elderly and/
or more clinically compromised populations.
The observation that additional carbohydrate ingestion is
not required to optimize post-prandial muscle protein syn-
thesis is of important clinical relevance. With a proposed
blunted muscle protein synthetic response in the elderly
population, the need for proper dietary intervention is well
recognized. Therefore, protein supplementation is pres-
ently being used in clinical practice to prevent or attenuate
muscle loss in the older population. However, in the light
of preventing excess energy intake and hyperglycemic
blood glucose excursions it has been questioned what food
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would be preferred to maximize post-prandial muscle pro-
tein accretion. The present study shows that large amounts
of carbohydrate are definitely not required to maximize
post-prandial muscle protein accretion to the ingestion of
a single 20 g bolus of dietary protein, suggesting that
products high in protein and low in carbohydrate are as
effective to stimulate muscle protein synthesis without in-
creasing energy intake.
We conclude that carbohydrate ingestion may accele-
rate, but does not further augment post-prandial incorpor-
ation of dietary protein derived amino acids into muscle
protein in healthy elderly men. This implies that ingestion
of carbohydrate is not required to optimize post-prandial
muscle protein accretion in the older population. This has
important clinical relevance for the development of cli-
nical nutrition for the elderly population.
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